Evolent Health, Inc.
Evolent Health, Inc. (EVH) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
evh · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Evolent Health, Inc. (EVH) measures how much investors pay for each dollar of the company's trailing earnings. EVH's current PE ratio of N/A is calculated by dividing its stock price of $4.66 by its TTM earnings per share of -$4.44.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2012 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Evolent Health, Inc.You EVH | $524M | N/A | — | -$4.44 |
 AMN Healthcare Services, Inc. AMN | $1.2B | N/A | — | -$2.48 |
 ArriVent BioPharma, Inc. Common Stock AVBP | $1.4B | N/A | — | -$4.32 |
 Butterfly Network, Inc. BFLY | $1.3B | N/A | — | -$0.31 |
 HealthStream, Inc. HSTM | $749M | 37.76x | — | $0.61 |
 Kura Oncology, Inc. KURA | $760M | N/A | — | -$3.18 |
 MeiraGTx Holdings plc MGTX | $842M | N/A | — | -$1.42 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-4.68 | — | |
2024-12-31 FY2024 | — | $-0.54 | — | |
2023-12-31 FY2023 | — | $-1.02 | — | |
2022-12-31 FY2022 | — | $-0.20 | — | |
2021-12-31 FY2021 | — | $-0.44 | — | |
2020-12-31 FY2020 | — | $-3.94 | — | |
2019-12-31 FY2019 | — | $-3.67 | — | |
2018-12-31 FY2018 | — | $-0.68 | — | |
2017-12-31 FY2017 | — | $-0.94 | — | |
2016-12-31 FY2016 | — | $-3.55 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Evolent Health, Inc. (EVH) measures how much investors pay for each dollar of the company's trailing earnings. EVH's current PE ratio of N/A is calculated by dividing its stock price of $4.66 by its TTM earnings per share of -$4.44.
Frequently asked questions
EVH pe ratio · 6 questionsEVH's current PE ratio is N/A as of 2026-06-08, based on a stock price of $4.66 and TTM EPS of -$4.44. Data sourced from Financial Modeling Prep via EVH's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Evolent Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08